Pfam Domains GO Terms
| CBF beta |
| core-binding factor complex |
| positive regulation of CD8-positive, alpha-beta T cell differentiation |
| positive regulation of CD8-positive, alpha-beta T cell activation |
| regulation of CD8-positive, alpha-beta T cell differentiation |
| regulation of CD8-positive, alpha-beta T cell activation |
| definitive hemopoiesis |
| negative regulation of CD4-positive, alpha-beta T cell differentiation |
| regulation of bicellular tight junction assembly |
| negative regulation of alpha-beta T cell differentiation |
| regulation of B cell receptor signaling pathway |
| negative regulation of CD4-positive, alpha-beta T cell activation |
| regulation of regulatory T cell differentiation |
| negative regulation of alpha-beta T cell activation |
| regulation of intracellular estrogen receptor signaling pathway |
| regulation of keratinocyte differentiation |
| negative regulation of T cell differentiation |
| positive regulation of alpha-beta T cell differentiation |
| regulation of CD4-positive, alpha-beta T cell differentiation |
| negative regulation of lymphocyte differentiation |
| regulation of megakaryocyte differentiation |
| positive regulation of alpha-beta T cell activation |
| regulation of CD4-positive, alpha-beta T cell activation |
| regulation of epidermal cell differentiation |
| regulation of antigen receptor-mediated signaling pathway |
| regulation of alpha-beta T cell differentiation |
| regulation of hematopoietic stem cell differentiation |
| regulation of intracellular steroid hormone receptor signaling pathway |
| transcription coregulator activity |
| positive regulation of T cell differentiation |
| regulation of epidermis development |
| regulation of hematopoietic progenitor cell differentiation |
| regulation of cell junction assembly |
| regulation of alpha-beta T cell activation |
| positive regulation of lymphocyte differentiation |
| negative regulation of leukocyte differentiation |
| negative regulation of T cell activation |
| regulation of stem cell differentiation |
| negative regulation of leukocyte cell-cell adhesion |
| osteoblast differentiation |
| negative regulation of hemopoiesis |
| regulation of T cell differentiation |
| regulation of epithelial cell differentiation |
| negative regulation of lymphocyte activation |
| positive regulation of leukocyte differentiation |
| cell maturation |
| regulation of cytokine-mediated signaling pathway |
| regulation of lymphocyte differentiation |
| negative regulation of leukocyte activation |
| negative regulation of cell-cell adhesion |
| regulation of response to cytokine stimulus |
| transcription initiation from RNA polymerase II promoter |
| positive regulation of hemopoiesis |
| negative regulation of cell activation |
| positive regulation of T cell activation |
| positive regulation of leukocyte cell-cell adhesion |
| DNA-templated transcription, initiation |
| myeloid cell differentiation |
| regulation of myeloid cell differentiation |
| lymphocyte differentiation |
| developmental maturation |
| positive regulation of cell-cell adhesion |
| ossification |
| regulation of leukocyte differentiation |
| negative regulation of cell adhesion |
| transcription coactivator activity |
| regulation of leukocyte cell-cell adhesion |
| protein polyubiquitination |
| regulation of T cell activation |
| leukocyte differentiation |
| positive regulation of lymphocyte activation |
| regulation of Wnt signaling pathway |
| lymphocyte activation |
| regulation of cell-cell adhesion |
| positive regulation of cell adhesion |
| positive regulation of leukocyte activation |
| positive regulation of cell activation |
| sequence-specific DNA binding |
| negative regulation of immune system process |
| regulation of hemopoiesis |
| transcription by RNA polymerase II |
| regulation of lymphocyte activation |
| hemopoiesis |
| regulation of leukocyte activation |
| hematopoietic or lymphoid organ development |
| regulation of cell activation |
| transcription, DNA-templated |
| nucleic acid-templated transcription |
| immune system development |
| RNA biosynthetic process |
| DNA-binding transcription factor activity |
| regulation of cell adhesion |
| protein ubiquitination |
| negative regulation of cell differentiation |
| protein modification by small protein conjugation |
| negative regulation of transcription by RNA polymerase II |
| leukocyte activation |
| negative regulation of developmental process |
| regulation of cellular component biogenesis |
| positive regulation of cell differentiation |
| protein modification by small protein conjugation or removal |
| cell activation |
| nucleobase-containing compound biosynthetic process |
| regulation of immune response |
| positive regulation of immune system process |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| negative regulation of transcription, DNA-templated |
| negative regulation of multicellular organismal process |
| positive regulation of transcription by RNA polymerase II |
| negative regulation of nucleic acid-templated transcription |
| negative regulation of RNA biosynthetic process |
| organic cyclic compound biosynthetic process |
| negative regulation of RNA metabolic process |
| positive regulation of developmental process |
| negative regulation of cellular macromolecule biosynthetic process |
| negative regulation of nucleobase-containing compound metabolic process |
| DNA binding |
| negative regulation of macromolecule biosynthetic process |
| negative regulation of cellular biosynthetic process |
| positive regulation of transcription, DNA-templated |
| negative regulation of biosynthetic process |
| DNA-binding transcription factor activity, RNA polymerase II-specific |
| cellular nitrogen compound biosynthetic process |
| positive regulation of nucleic acid-templated transcription |
| positive regulation of RNA biosynthetic process |
| cell development |
| regulation of immune system process |
| RNA metabolic process |
| cellular macromolecule biosynthetic process |
| negative regulation of gene expression |
| positive regulation of RNA metabolic process |
| positive regulation of multicellular organismal process |
| macromolecule biosynthetic process |
| regulation of cell differentiation |
| positive regulation of nucleobase-containing compound metabolic process |
| positive regulation of macromolecule biosynthetic process |
| positive regulation of cellular biosynthetic process |
| positive regulation of gene expression |
| membrane |
| gene expression |
| positive regulation of biosynthetic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Gene | Correlation |
|---|---|
| RPTOR | 0.643 |
| RUNX1 | 0.639 |
| BAP1 | 0.628 |
| NSD1 | 0.617 |
| DOHH | 0.609 |
| ID3 | 0.598 |
| DPAGT1 | 0.57 |
| XPO6 | 0.568 |
| SSBP2 | 0.568 |
| RNMT | 0.564 |
| THG1L | 0.558 |
| MED23 | 0.556 |
| TRIAP1 | 0.555 |
| PMM2 | 0.552 |
| WDR24 | 0.552 |
| GFPT1 | 0.548 |
| ALG5 | 0.547 |
| UHRF1 | 0.545 |
| GNB1L | 0.535 |
| MED16 | 0.533 |
| ZFX | 0.53 |
| UBE2G2 | 0.529 |
| UAP1 | 0.529 |
| CCDC101 | 0.527 |
| GMPPB | 0.526 |
| MTOR | 0.525 |
| TMEM41B | 0.525 |
| LMO2 | 0.524 |
| TRMT10A | 0.521 |
| TTI2 | 0.517 |
| LSM11 | 0.511 |
| ALG1 | 0.51 |
| GTF3C6 | 0.509 |
| AARS | 0.504 |
| VMP1 | 0.504 |
| SRP14 | 0.5 |
| TTI1 | 0.5 |
| NAE1 | 0.498 |
| GTF3C2 | 0.498 |
| MAML1 | 0.498 |
| CSNK2B | 0.495 |
| TAZ | 0.493 |
| PPA2 | 0.489 |
| CTDNEP1 | 0.486 |
| LDB1 | 0.486 |
| GTF2A2 | 0.485 |
| RTCB | 0.485 |
| ALG13 | 0.484 |
| OPA1 | 0.484 |
| UBE3A | 0.483 |
| SOX7 | 0.481 |
| DNAJC3 | 0.48 |
| MAPK14 | 0.478 |
| LAMTOR4 | 0.477 |
| TELO2 | 0.475 |
| MBTPS2 | 0.475 |
| EXOC4 | 0.474 |
| SEC63 | 0.473 |
| PELO | 0.472 |
| GTF3C4 | 0.471 |
| OTUD5 | 0.471 |
| MLLT1 | 0.47 |
| TLE4 | 0.47 |
| PPP2R3C | 0.467 |
| TRIM33 | 0.467 |
| HCCS | 0.466 |
| ALG6 | 0.465 |
| SLC25A26 | 0.465 |
| CBX3 | 0.463 |
| VHL | 0.462 |
| IRF2BP2 | 0.46 |
| TRNT1 | 0.46 |
| CHCHD4 | 0.459 |
| ATP5J | 0.459 |
| CRLS1 | 0.458 |
| PAM16 | 0.458 |
| ALG2 | 0.456 |
| RPN1 | 0.453 |
| ENY2 | 0.452 |
| BRD9 | 0.451 |
| PIK3R4 | 0.451 |
| FLI1 | 0.451 |
| SEC62 | 0.451 |
| DAD1 | 0.45 |
| ATP5B | 0.449 |
| LAMTOR5 | 0.449 |
| APAF1 | 0.448 |
| SSB | 0.447 |
| DHPS | 0.446 |
| CASP9 | 0.445 |
| ROMO1 | 0.445 |
| ATP5A1 | 0.445 |
| SLC35B1 | 0.444 |
| FNTA | 0.444 |
| MLST8 | 0.444 |
| PPCS | 0.444 |
| CCT7 | 0.442 |
| EIF4E | 0.442 |
| OSGEP | 0.441 |
| EIF1 | 0.44 |
| ATP5O | 0.439 |
| ATP2A2 | 0.438 |
| PLAA | 0.438 |
| HSPD1 | 0.437 |
| ZBTB44 | 0.437 |
| DERL2 | 0.436 |
| LSMD1 | 0.436 |
| SUPV3L1 | 0.435 |
| DPM3 | 0.435 |
| ZNF592 | 0.435 |
| ATF7IP | 0.435 |
| HAUS8 | 0.431 |
| VEZT | 0.43 |
| ATP5D | 0.43 |
| DPF2 | 0.43 |
| DHX29 | 0.429 |
| ZMYM2 | 0.428 |
| KDSR | 0.427 |
| WDR59 | 0.426 |
| ZNF410 | 0.426 |
| TRIM28 | 0.426 |
| RPP21 | 0.424 |
| BAK1 | 0.423 |
| SDHA | 0.423 |
| SRP72 | 0.423 |
| ARIH1 | 0.423 |
| VRK1 | 0.423 |
| ATXN10 | 0.423 |
| DHDDS | 0.422 |
| SCAF8 | 0.422 |
| PATZ1 | 0.42 |
| STT3A | 0.418 |
| TIMM13 | 0.418 |
| RFT1 | 0.417 |
| UTP23 | 0.415 |
| PGGT1B | 0.414 |
| TRMT5 | 0.413 |
| LSM10 | 0.412 |
| TMED10 | 0.412 |
| TOMM40 | 0.411 |
| DOLK | 0.411 |
| SLC25A19 | 0.41 |
| ASXL2 | 0.409 |
| WDR82 | 0.408 |
| PPP4C | 0.407 |
| TRIP12 | 0.407 |
| PDXK | 0.406 |
| MEF2C | 0.406 |
| ADSL | 0.406 |
| DDX20 | 0.406 |
| ELAC2 | 0.405 |
| ATP5I | 0.404 |
| PDPK1 | 0.404 |
| KIAA0391 | 0.403 |
| UBE2J1 | 0.403 |
| ATP5H | 0.402 |
| SEC61G | 0.401 |
| CMTR1 | 0.401 |
| FBXO11 | 0.4 |
| MRPS33 | 0.4 |
| FAF2 | 0.4 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 12/28 |
| bone | 0/26 |
| breast | 1/33 |
| central nervous system | 4/56 |
| cervix | 0/4 |
| colorectal | 1/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 3/20 |
| lung | 0/75 |
| lymphocyte | 1/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 5/15 |
| prostate | 0/1 |
| skin | 1/24 |
| soft tissue | 1/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 1/29 |
| uterus | 0/5 |
Expression Distribution